SR

Srinivasa Rao Kali Setti

Active Director Director DIN 10757170
DIN 10757170 First appointment Aug 2024 Primary industry Agriculture
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Srinivasa Rao Kali Setti

Data last updated:

Srinivasa Rao Kali Setti is a Director at Aeseepharmaceutical Private Limited (since 2024). The company operates in Agriculture.

DIN 10757170
Primary Designation Director
Industry Agriculture
First Appointment 28 Aug 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aeseepharmaceutical Private Limited U10803AP2024PTC115837
Director28 Aug 20242024Active

Board colleagues of Srinivasa Rao Kali Setti

NameDINCompanyDesignation
Sarika Kalisetti10757169Aeseepharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aeseepharmaceutical Private Limited
Premium access

Shareholding and investment profile for Srinivasa Rao Kali Setti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivasa Rao Kali Setti

Srinivasa Rao Kali Setti currently holds 1 directorship: Aeseepharmaceutical Private Limited (Director, since 28 Aug 2024).

Srinivasa Rao Kali Setti was first appointed on 28 Aug 2024 as Director at Aeseepharmaceutical Private Limited.

The current boards of Srinivasa Rao Kali Setti's companies include Sarika Kalisetti (Aeseepharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available